Methyl caffeate

Methyl caffeate has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest story, Nov 1, 2026: “Methyl caffeate binds a protein linked to human cell secretions”.

Intervention

1 paper studies it1 findingUpdated

PubChemChEBI

See all 1 papers on methyl caffeate

  • Cells1

What did studies of methyl caffeate find?

1

Studies of methyl caffeate measured one outcome, senescence-associated secretory phenotype (SASP).

Senescence-associated secretory phenotype (SASP)

downin reviews1

1 study
  1. Methyl caffeate inhibits senescence-associated secretory phenotype (SASP).

    “Methyl caffeate exhibits strong SASP-inhibitory activity”

    Review

    Methyl caffeate binds a protein linked to human cell secretions

    International journal of molecular sciences

More on Senescence-associated secretory phenotype (SASP)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
International Journal of Molecular Sciences

Methyl caffeate binds a protein linked to human cell secretions

In lab-grown human connective-tissue cells induced to stop dividing, reducing the protein also reduced release of two inflammatory signals.In lab-grown human connective-tissue cells induced to stop dividing, reducing the protein also reduced release of two inflammatory signals.

Human cell studyMechanisms